RoosterBio is an innovative mesenchymal stem cell (MSC) company that is focusing on democratizing stem cell manufacturing and ushering in a new era of regenerative medicine. 2016 has been a massive year for the company, as it recently announced a collaboration with BioBridge Global, as well as a co-branding partnership with the global filtration, separation and purification leader, Pall Corporation. [Read more…]
The agreement will encompass a co-development and marketing partnership.
OCTOBER 05, 2016 –Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial collaboration agreement with RoosterBio Inc, an innovative adult stem cell technology company. The agreement will encompass a co-development and marketing partnership, delivering complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs). [Read more…]
RoosterBio is an innovative company that provides standardized stem cell product platforms to enable rapid clinical and commercial translation. In today’s announcement, RoosterBio announced that it has entered into a Cooperative Research and Development Agreement (CRADA) that will enable “collaborative development of innovative stem cell-based therapies related to wounded warrior injuries and rehabilitation.” [Read more…]
In news released today, RoosterBio announced the “commercial launch of a new xeno-free version of their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium.” RoosterBio is an innovative company that provides standardized stem cell product platforms to enable rapid clinical and commercial translation.
Mesenchymal stem cells (MSC) are now more frequently cited than any other stem cell type within the scientific literature and Google Trend data shows MSC searches to be approximately twice as common as the next most common adult stem cell type. As a result of increases in MSC research frequency, it is important that companies like RoosterBio develop products to support efficient research processes.
To learn more, view our recent interview with Jon Rowley, RoosterBio’s CEO, or read the full press release issued by RoosterBio.
Designed by RoosterBio Inc: New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products
Highly efficient bioprocess media systems provide engineered solutions for rapid product development, manufacturing scale up and industrialization of stem cells.
FREDERICK, MD (PRWEB) JUNE 13, 2016 — RoosterBio Inc. announces the commercial launch of a new xeno-free version of their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This xeno-free media formulation extends RoosterBio’s portfolio of bioprocess media engineered to streamline culture processes, minimize processing time, significantly decrease production costs, reduce regulatory burden and simplify the transition into scalable platforms for clinical and commercial adult stem cell manufacturing. [Read more…]
Without question, some of BioInformant’s most popular content has been our exclusive interviews with stem cell executives and key opinion leaders (KOL). Highlighted below are six of our most popular interviews. Enjoy! [Read more…]